351 related articles for article (PubMed ID: 17123798)
21. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
Chieng N; Aaltonen J; Saville D; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
[TBL] [Abstract][Full Text] [Related]
22. Effect of gliclazide immobilization into layered double hydroxide on drug release.
Ambrogi V; Perioli L; Ciarnelli V; Nocchetti M; Rossi C
Eur J Pharm Biopharm; 2009 Oct; 73(2):285-91. PubMed ID: 19539757
[TBL] [Abstract][Full Text] [Related]
23. Ternary amorphous composites of celecoxib, poly(vinyl pyrrolidone) and meglumine with enhanced solubility.
Gupta P; Bansal AK
Pharmazie; 2005 Nov; 60(11):830-6. PubMed ID: 16320944
[TBL] [Abstract][Full Text] [Related]
24. Solid-state properties and crystallization behavior of PHA-739521 polymorphs.
Sun CC
Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086
[TBL] [Abstract][Full Text] [Related]
25. Effect of hydrotalcite-like compounds on the aqueous solubility of some poorly water-soluble drugs.
Ambrogi V; Fardella G; Grandolini G; Nocchetti M; Perioli L
J Pharm Sci; 2003 Jul; 92(7):1407-18. PubMed ID: 12820145
[TBL] [Abstract][Full Text] [Related]
26. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
27. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
28. Improvement of physical stability and dissolution rate of celecoxib suspensions by complexation with beta-cyclodextrins.
Chandra Sekhara Rao G; Satish Kumar M; Mathivanan N; Bhanoji Rao ME
Pharmazie; 2004 Aug; 59(8):627-30. PubMed ID: 15378853
[TBL] [Abstract][Full Text] [Related]
29. Dissolution of celecoxib from mucoadhesive disks based on polyaspartamide derivatives.
Krznar DB; Filipović-Grcić J; Zorc B; Zovko M
Acta Pharm; 2006 Dec; 56(4):463-71. PubMed ID: 19839138
[TBL] [Abstract][Full Text] [Related]
30. Co-relationship of physical stability of amorphous dispersions with enthalpy relaxation.
Bansal SS; Kaushal AM; Bansal AK
Pharmazie; 2008 Nov; 63(11):812-4. PubMed ID: 19069241
[TBL] [Abstract][Full Text] [Related]
31. Spray drying for generation of a ternary amorphous system of celecoxib, PVP, and meglumine.
Gupta P; Bansal AK
Pharm Dev Technol; 2005; 10(2):273-81. PubMed ID: 15926676
[TBL] [Abstract][Full Text] [Related]
32. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir.
Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714
[TBL] [Abstract][Full Text] [Related]
33. Adsorption removal of thiocyanate from aqueous solution by calcined hydrotalcite.
Li YJ; Yang M; Zhang XJ; Wu T; Cao N; Wei N; Bi YJ; Wang J
J Environ Sci (China); 2006; 18(1):23-8. PubMed ID: 20050543
[TBL] [Abstract][Full Text] [Related]
34. Wettability and surface chemistry of crystalline and amorphous forms of a poorly water soluble drug.
Puri V; Dantuluri AK; Kumar M; Karar N; Bansal AK
Eur J Pharm Sci; 2010 May; 40(2):84-93. PubMed ID: 20230893
[TBL] [Abstract][Full Text] [Related]
35. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis.
Zidan AS; Rahman Z; Sayeed V; Raw A; Yu L; Khan MA
Int J Pharm; 2012 Feb; 423(2):341-50. PubMed ID: 22100517
[TBL] [Abstract][Full Text] [Related]
36. Design and characterization of microcrystals for enhanced dissolution rate of celecoxib.
Lakshmi K; Reddy MP; Kaza R
Curr Drug Discov Technol; 2013 Dec; 10(4):305-14. PubMed ID: 24074306
[TBL] [Abstract][Full Text] [Related]
37. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose.
Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
Int J Pharm; 2006 Aug; 320(1-2):71-8. PubMed ID: 16750604
[TBL] [Abstract][Full Text] [Related]
38. Role of molecular interaction in stability of celecoxib-PVP amorphous systems.
Gupta P; Thilagavathi R; Chakraborti AK; Bansal AK
Mol Pharm; 2005; 2(5):384-91. PubMed ID: 16196491
[TBL] [Abstract][Full Text] [Related]
39. Purification of chromium(VI) finishing wastewaters using calcined and uncalcined Mg-Al-CO3-hydrotalcite.
Alvarez-Ayuso E; Nugteren HW
Water Res; 2005 Jul; 39(12):2535-42. PubMed ID: 15993462
[TBL] [Abstract][Full Text] [Related]
40. Impact of surfactants on the crystal growth of amorphous celecoxib.
Mosquera-Giraldo LI; Trasi NS; Taylor LS
Int J Pharm; 2014 Jan; 461(1-2):251-7. PubMed ID: 24333451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
